Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NStride APS in knee osteoarthritis
NCT02262364Phase 1Completed
- Sponsor
- Zimmer Biomet
- Start
- Nov 2014
- Primary completion
- Oct 2016
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of autologous protein solution in osteoarthritis (OA), sponsored by Zimmer Biomet. Primary endpoint: Adverse Events at 1 year. Started Nov 2014; status: completed.
02
Drugs
autologous protein solution
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02262364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02262364.